Further analysis of the spleen and TDLNs of these vaccinated mice validated a significant ex vivo activation of tumor‐pulsed splenocytes, determined by an increased proportion of IFN‐γ+ and TNF‐α+ CD44+ CD8+ T cells (Figure 6G). This evidence concerns the gene CD44 and neoplasm.